Release Date: 30/08/13 18:36 Summary: Appendix 4E - Preliminary Final Report Price Sensitive: Yes Download Document 209.55KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling